1 study on Zo 1 mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This research provides compelling evidence for the therapeutic utility of selectively modulating ILC subsets to combat chronic inflammatory conditions such as IBD. The ability of ILC-Mod-1 to rebalance ILC2/ILC3 popul…